Nanoscale Biophysics Group
- Scope: Biophysics of lipids and lipid-protein interactions; role of structural changes and physical properties of lipid monolayers and bilayers in controlling biological processes and diseases; application of lipid films in biomedical nanotechnology
- Current Research Projects: role of lipid membrane in amyloid toxicity in relation to Alzheimer's Disease; testing amyloid inhibitor drugs using single molecule atomic force spectroscopy, interaction of antimicrobial peptides with lipid membrane and lung surfactant; lipid-based drug delivery systems, developing novel biosensing platforms using lipid membrane and surface enhanced spectroscopy
- Methods: Optical, Fluorescence and Scanning Probe Microscopy (SPM) such as Atomic Force Microscopy (AFM), Kelvin Probe Force Microscopy (KPFM) and AFM-based Force Measurements; Langmuir-Blodgett Monolayer Technique; Surface Enhanced Spectroscopy; Novel Biological Applications of Frequency Modulation KPFM (FM-KPFM) Technique
- Research is funded by: Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institute for Health Research (CIHR), Canada Foundation for Innovation (CFI), Ontario Ministry of Research & Innovation
- We are actively looking for commercial partners. Please contact Dr. Zoya Leonenko at email@example.com!
- Oct. 19, 2016
Congratulations to Brenda Lee, PhD Candidate in Biology (Nanotechnology), for receiving one of this year's WIN Nanofellowships for her interdisciplinary work with antimicrobial peptides.
- May 31, 2016
Congratulations to Robbie Henderson, our recent PhD Physics graduate, for being accepted to medical school at multiple universities! The Nanoscale Biophysics Group wishes you a successful and prosperous medical career starting at the University of Saskatchewan!
- May 3, 2016
Congratulations to Brenda Lee on having the best PhD Seminar at the Biology Graduate Student Symposium that took place on Friday, April 29th.
The title of her talk was "Binding and Insertion Studies of Antimicrobial Peptide Daptomycin and Derivative CB-182,462 with Model Lipid Monolayers and Membranes".